Atomfair 6,7-Dihydrocyclopenta[C]pyridin-5-one C8H7NO

Description 6,7-Dihydrocyclopenta[C]pyridin-5-one (CAS No. 350847-80-2) is a high-purity heterocyclic organic compound with the molecular formula C8H7NO . This versatile building block features a cyclopenta[c]pyridine core structure with a ketone functionality at the 5-position, making it valuable for pharmaceutical and materials science research. The compound is supplied as a crystalline solid with >95% purity (HPLC) and is rigorously tested for consistency in quality. Ideal for use in medicinal chemistry, it serves as a key intermediate in the synthesis of bioactive molecules, kinase inhibitors, and other nitrogen-containing heterocycles. Proper storage at 2-8??C under inert atmosphere is recommended to maintain stability.

Description

Description

6,7-Dihydrocyclopenta[C]pyridin-5-one (CAS No. 350847-80-2) is a high-purity heterocyclic organic compound with the molecular formula C8H7NO. This versatile building block features a cyclopenta[c]pyridine core structure with a ketone functionality at the 5-position, making it valuable for pharmaceutical and materials science research. The compound is supplied as a crystalline solid with >95% purity (HPLC) and is rigorously tested for consistency in quality. Ideal for use in medicinal chemistry, it serves as a key intermediate in the synthesis of bioactive molecules, kinase inhibitors, and other nitrogen-containing heterocycles. Proper storage at 2-8??C under inert atmosphere is recommended to maintain stability.

  • CAS No: 350847-80-2
  • Molecular Formula: C8H7NO
  • Molecular Weight: 133.15
  • Exact Mass: 133.052763847
  • Monoisotopic Mass: 133.052763847
  • IUPAC Name: 6,7-dihydrocyclopenta[c]pyridin-5-one
  • SMILES: C1CC(=O)C2=C1C=NC=C2
  • Synonyms: 6,7-dihydrocyclopenta[c]pyridin-5-one, 6,7-DIHYDROCYCLOPENTA(C)PYRIDIN-5-ONE, 854-155-1, 6,7-dihydro-5H-cyclopenta[c]pyridin-5-one, 350847-80-2

Application

6,7-Dihydrocyclopenta[C]pyridin-5-one is primarily used as a scaffold in medicinal chemistry for developing kinase inhibitors and CNS-active compounds. Its fused bicyclic structure enables ??-stacking interactions in drug-receptor binding. Researchers utilize this intermediate in palladium-catalyzed cross-coupling reactions to construct complex pharmacophores. The ketone moiety allows further derivatization via reductive amination or nucleophilic addition.

If you are interested or have any questions, please contact us at support@atomfair.com